Pregnant women who develop ANCA-associated vasculitis (AAV)Â may safely receive Rituxan (rituximab) and corticosteroids, a case study suggests. However,…
Articles by Janet Stewart, MSc
InflaRx will soon begin a Phase 2 clinical trial assessing the safety and effectiveness of IFX-1 — an inhibitor of…
Some patients with ANCA-associated vasculitis (AAV) caused by hydralazine — a medication used to treat high blood pressure — develop end-stage…
A new study found why some patients with ANCA-associated vasculitis (AAV) have autoantibodies in the blood, but not at the…
The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on to standard care for treating…
Dutch scientists have identified different genes in Staphylococcus aureus — a kind of bacteria carried in the nostrils — in either patients…
A review about the anti-neutrophil cytoplasmic antibody (ANCA) glomerulonephritis and vasculitis outlined the best way to characterize the different kinds of…